Cargando…

Phosphate-modif ied CpG oligonucleotides induce in vitro maturation of human myeloid dendritic cells

Myeloid dendritic cells (DCs) play an important role in the immune response; therefore, the search for compounds that can effectively activate DCs is a needful goal. This study was aimed to investigate the effect of synthetic CpG oligodeoxynucleotides (CpG-ODN) on the maturation and allostimulatory...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ostanin, A.A., Leplina, O.Y., Burakova, E.A., Tyrinova, T.V., Fokina, A.A., Proskurina, A.S., Bogachev, S.S., Stetsenko, D.A., Chernykh, E.R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Federal Research Center Institute of Cytology and Genetics of Siberian Branch of the Russian Academy of Sciences 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716551/ https://www.ncbi.nlm.nih.gov/pubmed/33659851 http://dx.doi.org/10.18699/VJ20.659

Ejemplares similares

Antitumor efficacy of multi-target in situ vaccinations with CpG oligodeoxynucleotides, anti-OX40, anti-PD1 antibodies, and aptamers
por: Proskurina, Anastasia S., et al.
Publicado: (2023)

Autologous and Pooled Tumor Lysates in Combined Immunotherapy of Patients with Glioblastoma
por: Mishinov, S.V., et al.
Publicado: (2020)

Defective Regulation of Membrane TNFα Expression in Dendritic Cells of Glioblastoma Patients Leads to the Impairment of Cytotoxic Activity against Autologous Tumor Cells
por: Tyrinova, Tamara, et al.
Publicado: (2020)

Theoretical premises of a “three in one” therapeutic approach to treat immunogenic and nonimmunogenic cancers: a narrative review
por: Proskurina, Anastasia S., et al.
Publicado: (2021)

Mesyl phosphoramidate antisense oligonucleotides as an alternative to phosphorothioates with improved biochemical and biological properties
por: Miroshnichenko, S. K., et al.
Publicado: (2019)

Elevated levels of dehydroepiandrosterone as a potential mechanism of dendritic cell impairment during pregnancy
por: Chernykh, Elena R, et al.
Publicado: (2015)

Chemistry of Peptide-Oligonucleotide Conjugates: A Review
por: Klabenkova, Kristina, et al.
Publicado: (2021)

Cytotoxic Activity of Dendritic Cells as a Possible Mechanism of Negative Regulation of T Lymphocytes in Pulmonary Tuberculosis
por: Sakhno, Ludmila V., et al.
Publicado: (2012)

Analysis of the Biological Properties of Blood Plasma Protein with GcMAF Functional Activity
por: Dolgova, Evgeniya V., et al.
Publicado: (2022)

CpG Oligonucleotides as Cancer Vaccine Adjuvants
por: Shirota, Hidekazu, et al.
Publicado: (2015)

The revival of CpG oligonucleotide-based cancer immunotherapies
por: Adamus, Tomasz, et al.
Publicado: (2018)

Enhanced gene repair mediated by methyl-CpG-modified single-stranded oligonucleotides
por: Bertoni, Carmen, et al.
Publicado: (2009)

Cancer Stem Cells: Emergent Nature of Tumor Emergency
por: Efremov, Yaroslav R., et al.
Publicado: (2018)

Functional Downregulation of PD-L1 and PD-L2 by CpG and non-CpG Oligonucleotides in Melanoma Cells
por: Kleemann, Johannes, et al.
Publicado: (2022)

Thermolytic CpG-containing DNA oligonucleotides as potential immunotherapeutic prodrugs
por: Grajkowski, Andrzej, et al.
Publicado: (2005)

DEC-205 is a cell surface receptor for CpG oligonucleotides
por: Caminschi, Irina, et al.
Publicado: (2013)

Novel Cancer Stem Marker and Its Applicability for Grading Primary Human Gliomas
por: Dolgova, Evgeniya V., et al.
Publicado: (2018)

Synthetic Hexanucleotides as a Tool to Overcome Excessive Neutrophil Activation Caused by CpG-Containing Oligonucleotides
por: Golenkina, Ekaterina A., et al.
Publicado: (2021)

Preservation of methylated CpG dinucleotides in human CpG islands
por: Panchin, Alexander Y., et al.
Publicado: (2016)

Effect of Calcium Carbonate Encapsulation on the Activity of Orally Administered CpG Oligonucleotides
por: Kayraklioglu, Neslihan, et al.
Publicado: (2017)

Effects of Recombinant Angiogenin on Collagen Fiber Formation and Angiogenesis in the Dermis of Wistar Rats
por: Yurina, Natalia V, et al.
Publicado: (2021)

The counter regulatory response induced by CpG oligonucleotides prevents bleomycin induced pneumopathy
por: Kinjo, Takeshi, et al.
Publicado: (2012)

Evaluation of single CpG sites as proxies of CpG island methylation states at the genome scale
por: Barrera, Víctor, et al.
Publicado: (2012)

Efficacy of a new cancer treatment strategy based on eradication of tumor-initiating stem cells in a mouse model of Krebs-2 solid adenocarcinoma
por: Potter, Ekaterina A., et al.
Publicado: (2018)

CpG oligonucleotide activates Toll-like receptor 9 and causes lung inflammation in vivo
por: Knuefermann, Pascal, et al.
Publicado: (2007)

Erratum to: Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer
por: Proskurina, Anastasia S., et al.
Publicado: (2016)

Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer
por: Proskurina, Anastasia S, et al.
Publicado: (2015)

Five-year disease-free survival among stage II-IV breast cancer patients receiving FAC and AC chemotherapy in phase II clinical trials of Panagen
por: Proskurina, Anastasia S., et al.
Publicado: (2016)

The Effects of O(6)-methyl Guanine DNA-methyl Transferase Promotor Methylation and CpG1, CpG2, CpG3 and CpG4 Methylation on Treatment Response and their Prognostic Significance in Patients with Glioblastoma
por: Yildiz, OG, et al.
Publicado: (2020)

Chronometric Administration of Cyclophosphamide and a Double-Stranded DNA-Mix at Interstrand Crosslinks Repair Timing, Called “Karanahan” Therapy, Is Highly Efficient in a Weakly Immunogenic Lewis Carcinoma Model
por: Ruzanova, Vera, et al.
Publicado: (2022)

Pre-conditioning with synthetic CpG-oligonucleotides attenuates myocardial ischemia/reperfusion injury via IL-10 up-regulation
por: Markowski, P., et al.
Publicado: (2013)

The new general biological property of stem-like tumor cells Part I. Peculiarities of the process of the double-stranded DNA fragments internalization into stem-like tumor cells
por: Ritter, Genrikh S., et al.
Publicado: (2022)

The New General Biological Property of Stem-like Tumor Cells (Part II: Surface Molecules, Which Belongs to Distinctive Groups with Particular Functions, Form a Unique Pattern Characteristic of a Certain Type of Tumor Stem-like Cells)
por: Petrova, Daria D., et al.
Publicado: (2022)

Prophylactic Application of CpG Oligonucleotides Augments the Early Host Response and Confers Protection in Acute Melioidosis
por: Judy, Barbara M., et al.
Publicado: (2012)

CpG oligonucleotides bind TLR9 and RRM-Containing proteins in Atlantic Salmon (Salmo salar)
por: Iliev, Dimitar B, et al.
Publicado: (2013)

Evaluation of Different Oligonucleotide Base Substitutions at CpG Binding sites in Multiplex Bisulfite-PCR sequencing
por: Lu, Jennifer, et al.
Publicado: (2017)

CpG Oligonucleotides Protect Mice From Alphavirus Encephalitis: Role of NK Cells, Interferons, and TNF
por: Manangeeswaran, Mohanraj, et al.
Publicado: (2020)

Exposure to unmethylated CpG oligonucleotides disrupts blood pressure circadian rhythms and placental clock gene network in pregnant rats
por: Bradshaw, Jessica L., et al.
Publicado: (2023)

Methyl CpG binding protein 2 (MeCP2) enhances photodimer formation at methyl-CpG sites but suppresses dimer deamination
por: Cannistraro, Vincent J., et al.
Publicado: (2010)

Suppressive CpG
por: Van Epps, Heather L.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_udntj0lh0vi85ih7j7tuf0nj77